Yukon Wealth Management Inc. Makes New Investment in McKesson Corporation $MCK

Yukon Wealth Management Inc. purchased a new position in shares of McKesson Corporation (NYSE:MCK) during the 2nd quarter, Holdings Channel reports. The institutional investor purchased 1,082 shares of the company’s stock, valued at approximately $818,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of MCK. University of Texas Texas AM Investment Management Co. bought a new stake in shares of McKesson in the 4th quarter worth approximately $25,000. Swiss RE Ltd. acquired a new position in McKesson during the 4th quarter valued at approximately $26,000. Delos Wealth Advisors LLC bought a new position in McKesson during the 2nd quarter worth $27,000. State of Wyoming bought a new position in McKesson during the 2nd quarter worth $29,000. Finally, Kingdom Financial Group LLC. acquired a new stake in McKesson in the fourth quarter worth $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,463 shares of the company’s stock in a transaction on Tuesday, July 7th. The stock was sold at an average price of $793.56, for a total value of $6,715,898.28. Following the transaction, the chief executive officer directly owned 5,919 shares of the company’s stock, valued at $4,697,081.64. This represents a 58.84% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Thomas L. Rodgers sold 699 shares of the company’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $735.27, for a total transaction of $513,953.73. Following the transaction, the executive vice president owned 2,268 shares of the company’s stock, valued at $1,667,592.36. This trade represents a 23.56% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 23,111 shares of company stock valued at $18,011,274 over the last ninety days. 0.06% of the stock is currently owned by company insiders.

McKesson Stock Down 0.7%

Shares of MCK opened at $890.20 on Friday. The stock’s 50-day moving average price is $830.40 and its 200 day moving average price is $843.76. The firm has a market capitalization of $103.79 billion, a price-to-earnings ratio of 23.82, a P/E/G ratio of 1.76 and a beta of 0.30. McKesson Corporation has a 12-month low of $677.28 and a 12-month high of $999.00.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, topping analysts’ consensus estimates of $9.56 by $0.37. The company had revenue of $105.38 billion for the quarter, compared to analyst estimates of $103.88 billion. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The business’s revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $8.26 earnings per share. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Equities research analysts expect that McKesson Corporation will post 44.65 EPS for the current year.

McKesson Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be issued a $0.94 dividend. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. This is a boost from McKesson’s previous quarterly dividend of $0.82. The ex-dividend date is Tuesday, September 1st. McKesson’s dividend payout ratio is 8.78%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on MCK shares. Weiss Ratings cut shares of McKesson from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, July 7th. Barclays increased their target price on shares of McKesson from $925.00 to $1,000.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. TD Cowen lifted their price target on shares of McKesson from $989.00 to $1,006.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Evercore reaffirmed an “outperform” rating on shares of McKesson in a report on Thursday, August 6th. Finally, Royal Bank Of Canada began coverage on McKesson in a report on Wednesday, August 19th. They issued a “sector perform” rating and a $845.00 price target on the stock. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $973.44.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.